MedPage is reporting that a secret test nabbed three riders for using a banned new form of erythropoietin. The drug is CERA (Mircera), a pegylated EPO developed by Roche that reached the European market earlier this year. It was approved by the FDA last November, but U.S. distribution has been stalled by a patent dispute with Amgen, another firm that markets EPO. 

My Take?